Abstract
We assessed feasibility and outcome of hepatitis C virus (HCV) treatment in male correctional inmates in British Columbia, Canada. We reviewed the medical charts of 114 treated inmates; 80 had complete data for treatment outcome. Approximately 4 of 5 inmates completed treatment (78.8%); 66.3% achieved sustained virological response. Those who completed treatment, those with injection drug use as a risk factor, and those with genotypes 2 and 3 were significantly more likely to achieve sustained virological response. HCV treatment in correctional inmates is feasible and effective.
Publication types
-
Evaluation Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
British Columbia / epidemiology
-
DNA, Viral / genetics
-
Drug Combinations
-
Feasibility Studies
-
Federal Government
-
Genotype
-
Hepacivirus / classification
-
Hepacivirus / genetics
-
Hepatitis C / drug therapy*
-
Hepatitis C / epidemiology
-
Hepatitis C / etiology
-
Humans
-
Interferon-alpha / therapeutic use*
-
Male
-
Methadone / therapeutic use
-
Middle Aged
-
Multivariate Analysis
-
Narcotics / therapeutic use
-
Prevalence
-
Prisons / organization & administration*
-
Program Evaluation
-
Retrospective Studies
-
Ribavirin / therapeutic use*
-
Risk Factors
-
Substance Abuse, Intravenous / complications
-
Substance Abuse, Intravenous / drug therapy
-
Treatment Outcome
Substances
-
DNA, Viral
-
Drug Combinations
-
Interferon-alpha
-
Narcotics
-
Rebetron
-
Ribavirin
-
Methadone